Viewing nowPoglin 10 mg (Dapagliflozin Propanediol Hydrate)
Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
Hana Pharmaceutical Co., Ltd.

MFDS item code 202202271 · Approved 2022.05.30 · Insurance code 657807800
Improvement of glycemic control in type 2 diabetes mellitus
This drug plays a complementary role in improving blood sugar control in patients with type 2 diabetes by supplementing dietary and exercise therapies. It can be used alone or in combination with other medications. It should be used cautiously in patients with cardiovascular disease or risk factors among those whose blood sugar is not adequately controlled. It is important to manage it safely with reference to expert clinical trial information when taking it. Overall, this drug is effective in the treatment of type 2 diabetes and improves blood sugar control.
Type 2 diabetes mellitus Monotherapy and add-on combination therapy The recommended dose of this medicine is 10mg once daily for monotherapy and add-on combination therapy with other blood glucose-lowering agents, such as insulin. When this medicine is used in combination with insulin or insulin secretagogues such as sulfonylureas, a lower dose of insulin or the insulin secretagogue may be considered to reduce the risk of hypoglycemia. Initial combination therapy For patients with no prior history of antidiabetic drug treatment who are receiving this medicine in combination with metformin, the recommended initial dose is 5mg once daily or 10mg once daily. Special populations Renal impairment - eGFR < 45 mL/min/1.73m2: Use of this medicine to improve glycemic control is not recommended. - Patients on dialysis: Do not administer this medicine. Hepatic impairment No dose adjustment is necessary in patients with mild or moderate hepatic impairment. For patients with severe hepatic impairment, an initial dose of 5mg is recommended. If well tolerated, this dose may be increased to 10mg. Elderly (≥ 65 years) Dose adjustment based on age is not recommended. Method of administration This medicine may be administered orally once daily at any time of day, with or without food. Tablets should be swallowed whole.
Children under 18 years of age: The efficacy and safety of dapagliflozin in children under 18 years of age have not been established. No relevant data are available.
This drug should not be used in patients with allergies to the main ingredient or excipients. It should not be administered to patients with type 1 diabetes or diabetic ketoacidosis. It is also not suitable for patients with lactose intolerance or certain genetic metabolic disorders. It should not be used in patients receiving dialysis. Use with caution in patients with volume depletion or renal function problems. This drug may lower blood pressure or cause temporary changes in renal function, necessitating caution. Patients with impaired renal function, the elderly, and those taking diuretics should closely monitor their fluid status and renal function. During treatment with this drug, there may be occurrences of genital infections and urinary tract infections, so if related symptoms appear, immediate consultation with healthcare professionals is necessary. There is a risk of hypoglycemia, so dosage adjustments may be needed when used with insulin or sulfonylureas. If dehydration or hypotension symptoms occur, it is advisable to temporarily stop taking this drug and consult a healthcare professional. Severe metabolic abnormalities known as diabetic ketoacidosis may occur, so immediate examination is needed if symptoms such as vomiting, abdominal pain, or difficulty breathing arise. It is safest for women who are pregnant or breastfeeding not to use this drug, and if pregnancy is confirmed, it should be discontinued. Elderly patients have a higher risk of decreased renal function and reduced fluid volume, so caution should be exercised. This drug may increase urination, so patients with bladder-related diseases should consider the possibility of condition worsening when using it. In case of overdose, as there are no specific antidotes, appropriate treatment should be undertaken based on symptoms, and attention should be paid to dehydration or hypotension symptoms. During treatment with this drug, caution should be exercised for hypoglycemia symptoms while driving or operating machinery, especially when taken with insulin or sulfonylureas. The safety and efficacy of this drug have not been established in children, so it is not used in that population. When storing the drug, keep it out of the reach of children and store it in its original container to maintain quality.
Vulvovaginitis, balanitis and related genital infections, urinary tract infections, fungal infections, perineal necrosis, hypoglycemia, reduced fluid volume, thirst, diabetic ketoacidosis, dizziness, constipation, dry mouth, back pain, dysuria, polyuria, nocturia, interstitial nephritis, vulvar pruritus, genital pruritus, increased hematocrit, decreased initial renal creatinine clearance, dyslipidemia, increased initial serum creatinine, elevated blood urea, weight loss, acute pyelonephritis, rash, angioedema, asthenia, pain, keratitis, chronic obstructive pulmonary disease, hemoptysis, cerebral hemorrhage, peripheral artery occlusion, angina, myocardial infarction, choledocholithiasis, cholangitis, alcoholic cirrhosis, depression, suicide attempt, gastric cancer, anaphylactic reaction, paresthesia, cerebral infarction, nerve compression, sensory loss, headache, palpitations, insomnia, tinnitus, dyspepsia, nausea, diarrhea, vomiting, urinary retention, increased alanine aminotransferase, increased aspartate aminotransferase, reduced appetite, next-day phenomenon, taste disturbance, nasopharyngitis, upper respiratory infection, edema, fever, foreign body sensation, facial edema, facial pain, warmth, influenza-like syndrome, vaginal discharge, menstrual irregularity, itching, urticaria, excessive sweating, arthralgia, musculoskeletal pain, limb pain, muscle weakness, myalgia, osteoarthritis, ligament sprain, diabetic retinopathy, cough, dyspnea, orthostatic hypotension, anxiety disorder, enuresis, fatty liver, gallbladder polyps, dizziness, anal genital warts, breast mass, erectile dysfunction, benign prostatic hyperplasia, breast pain, genital rash, menorrhagia, genital edema, uterine bleeding, vaginal bleeding, vulvar discomfort, hair loss, dermatitis, dry skin, allergic dermatitis, contact dermatitis, diabetic foot ulcer, sweating abnormal eczema, nummular eczema, eczema, hyperkeratosis, nail pigmentation, skin lesions, excessive sweating, dermatitis, dry skin, hyperkeratosis, skin lesions, flank pain, myofascial pain, limb discomfort, muscle cramps, musculoskeletal discomfort, osteopenia, contusion, road traffic accident, drug overdose, ankle fracture, orbital fracture, foot fracture, gastrointestinal foreign body, hand fracture, pelvic fracture, laceration, ligament rupture, limb injury, meniscus injury, skin abrasion, tendon rupture, thoracic vertebra fracture, tibia fracture, dental injury, dry eye, eye pain, retinal disorders, vision reduction, blepharitis, cataract, conjunctival edema, allergic conjunctivitis, conjunctivitis, diplopia, eyelid edema, keratitis, ocular hypertension, visual impairment, vitreous floaters, oropharyngeal pain, allergic rhinitis, asthma, voice disorder, epistaxis, sputum, sleep apnea syndrome, wheezing, arteriosclerosis, flushing, peripheral coldness, varicose veins, vascular headache, angina, atrial fibrillation, diastolic dysfunction, palpitations, auditory hallucinations, suicide attempt, gallbladder polyps, liver cysts, male gonadal insufficiency, thyroid cysts, thyroid masses, anaphylactic reaction, food allergy, erythrocytosis
Not everyone experiences these, and they can vary from person to person.
This drug may be sensitive to air or moisture, so it should be stored in a sealed container. It is best to maintain storage temperatures between 1 degree and 30 degrees Celsius at room temperature. This way, the drug's efficacy can be preserved for a long time.
Yellow, biconvex, diamond-shaped film-coated tablet
PTP - 28 tablets/box [28 tablets (7 tablets/PTP x 4)], bottle - 30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowDapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
Hana Pharmaceutical Co., Ltd.
Dapagliflozin Propanediol Hydrate 6.15mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.
Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
Donggu Bio Pharmaceutical Co., Ltd.
Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
Il Sung IS Co., Ltd.
Dapagliflozin Propanediol Hydrate
Prescription medication
Optus Pharmaceutical Co., Ltd.

Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
Aprogen Biologics Co., Ltd.

Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
Il Yang Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.